Impact of Primary Care COPD Screening Strategies on the Smoking Cessation Process (DISCO-SET)
NCT ID: NCT04833933
Last Updated: 2021-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2021-04-07
2021-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Each year, 3-5% of smokers succeed in quitting in the general population. The corollary is that the majority of smokers are in a situation of failure in their attempt to quit: 33% declared during the 2019 French Health Barometer to have made an attempt of at least 7 days in the past year. Thus, this status of "smoker" can cover a wide variety of situations: no attempt to stop smoking, attempt(s) of more or less clinical significance, previous support or not by a health professional, etc. Currently, the HAS recommendations do not determine a specific course of action for these smokers, whose experiences may be very different. It could therefore be interesting to objectivize the smoking cessation process of these patients who have or have not succeeded in quitting, in order to deduce profiles of smokers according to their previous smoking cessation experiences. Furthermore, the choice and relevance of the cessation criteria used are debated.
Following the randomized controlled trial DISCO on COPD screening interventions in primary care (3 intervention arms, 1 control arm), the investigators will carry out a pilot cross-sectional survey on the cessation process of smokers during the 2 years following their participation, evaluating the incidence and modalities of cessation attempts of smokers belonging to an age group at risk of COPD (40-80 years) and who initially consulted their general practitioner for any reason 2 years ago at the time of their inclusion.
The impact on future management could be the personalization of cessation advice given to smokers according to quantitative and qualitative indicators specific to their experience, their previous history of smoking cessation, their health situation and socio-demographic characteristics. Eventually, a gradation of the levels of support offered to patients in general practice on the basis of predictive factors of smoking cessation could be studied.
The investigators hypothesize that participation in COPD screening with the GP may be associated with patient progress in quitting smoking. This pilot study will be conducted on a random sample of 120 participants from the subgroup of 544 patients who were smokers at inclusion in DISCO.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Initially in DISCO trial : no intervention, usual care
In DISCO-SET trial : survey (the same in the 4 groups)
Phone survey about smoking cessation process since intervention in DISCO trial
We will conduct a phone survey at 2 years follow-up with a random sample of smoking patients at inclusion in DISCO trial, to know the evolution of their smoking habits, the quit attempts since the intervention and the modalities of these attempts.
Questionnaire
Initially in DISCO trial : Targeted screening of COPD by GPs via the GOLD / HAS questionnaire. The questionnaire includes 4 questions for patients over 40. At least one positive response is an indication to perform a spirometry.
In DISCO-SET trial : survey (the same in the 4 groups)
Phone survey about smoking cessation process since intervention in DISCO trial
We will conduct a phone survey at 2 years follow-up with a random sample of smoking patients at inclusion in DISCO trial, to know the evolution of their smoking habits, the quit attempts since the intervention and the modalities of these attempts.
Coordination
Initially in DISCO trial : Information of the GPs of the existence of a coordination of the care of proximity to facilitate the access to the spirometry (identification of a referent specialist, making appointments).
In DISCO-SET trial : survey (the same in the 4 groups)
Phone survey about smoking cessation process since intervention in DISCO trial
We will conduct a phone survey at 2 years follow-up with a random sample of smoking patients at inclusion in DISCO trial, to know the evolution of their smoking habits, the quit attempts since the intervention and the modalities of these attempts.
Questionnaire + Coordination
Initially in DISCO trial :
* Targeted screening of COPD by GPs via the GOLD / HAS questionnaire. The questionnaire includes 4 questions for patients over 40. At least one positive response is an indication to perform a spirometry.
* Information of the GPs of the existence of a coordination of the care of proximity to facilitate the access to the spirometry (identification of a referent specialist, making appointments).
In DISCO-SET trial : survey (the same in the 4 groups)
Phone survey about smoking cessation process since intervention in DISCO trial
We will conduct a phone survey at 2 years follow-up with a random sample of smoking patients at inclusion in DISCO trial, to know the evolution of their smoking habits, the quit attempts since the intervention and the modalities of these attempts.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phone survey about smoking cessation process since intervention in DISCO trial
We will conduct a phone survey at 2 years follow-up with a random sample of smoking patients at inclusion in DISCO trial, to know the evolution of their smoking habits, the quit attempts since the intervention and the modalities of these attempts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No objection to participate in the study,
* Patient still followed in the active file of general practitioners' offices (GP).
* Patient's telephone and postal details available
Exclusion Criteria
* Patient deceased,
* Patient not reachable despite 5 phone calls and message left on answering machine.
* Patient under curatorship, guardianship or safeguard of justice
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno LAVIOLLE, PhD
Role: STUDY_CHAIR
Rennes UH
Anthony CHAPRON, PhD
Role: PRINCIPAL_INVESTIGATOR
Faculty of medicine of rennes
Anthony CHAPRON, PhD
Role: STUDY_DIRECTOR
Faculty of medicine of rennes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emmanuelle FOURE-AMELOT
Bédée, Brittany Region, France
Béatrice NEGARET
Breteil, Brittany Region, France
Lucie DELATTE
Janzé, Brittany Region, France
Marie BROSSET
Miniac-Morvan, Brittany Region, France
Antoine MOUTEL
Redon, Brittany Region, France
Anna JARNO-JOSSE
Rennes, Brittany Region, France
Hoël CHARBONNEL
Rennes, Brittany Region, France
Romain NIFENECKER
Rennes, Brittany Region, France
Jean-Philippe DUGUEY
St-Malo, Brittany Region, France
Laurent LENOBLE
Sulniac, Brittany Region, France
Lucie MURGALE
Talensac, Brittany Region, France
Marieke SALACROUP
Tremblay, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35RC21_9742_DISCO-SET
Identifier Type: -
Identifier Source: org_study_id